CellTrend diagnostic test: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - " | first1" to "| first1") |
Notjusttired (talk | contribs) m (Text replacement - " | first6" to "| first6") |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Loebel, 2016">{{Citation | last1 = Loebel | first1 = M | authorlink1 = Madlen Loebel | last2 = Grabowski | first2 = P | authorlink2 = Patricia Grabowski | last3 = Heidecke | first3 = H | authorlink3 = | last4= Bauer| first4 = S | authorlink4 = Sandra Bauer | last5 =Hanitsch | first5 = LG | authorlink5 = | last6 = Wittke | <ref name="Loebel, 2016">{{Citation | last1 = Loebel | first1 = M | authorlink1 = Madlen Loebel | last2 = Grabowski | first2 = P | authorlink2 = Patricia Grabowski | last3 = Heidecke | first3 = H | authorlink3 = | last4= Bauer| first4 = S | authorlink4 = Sandra Bauer | last5 =Hanitsch | first5 = LG | authorlink5 = | last6 = Wittke| first6 = K | authorlink6 = | last7 = Meisel| first7 = C | authorlink7 = | last8 = Reinke | first8 = P | authorlink8 = | last9 = Volk | first9 = H | authorlink9 = | last10 = Fluge | first10 = Ø | authorlink10 = Øystein Fluge | last11 = Mella | first11 = O | authorlink11 = Olav Mella | last12 = Scheibenbogen | first12 = C | authorlink12 = Carmen Scheibenbogen | title = Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome | journal = Brain, behavior, and immunity | volume = 52 | issue = | page = 32-39 | date =2016 | doi = 10.1016/j.bbi.2015.09.013 }}</ref> | ||
</references> | </references> | ||
[[Category:Medical tests]] | [[Category:Medical tests]] | ||
Revision as of 11:30, October 7, 2022
The CellTrend Diagnostic Test is a commercial ME/CFS diagnostic immunoassay created by CellTrend, a German biotechnology company, and Professor Doctor Carmen Scheibenbogen. Cell-Trend bases its test on the theory that a subset of 20-30% of all patients suffering from ME/CFS have developed elevated levels of three auto-antibodies, i.e., auto-antibodies against the b2-adrenergic receptor, auto-antibodies against the muscarinic cholinergic receptor 3 (M3) and auto-antibodies against the muscarinic cholinergic receptor 4 (M4). The CellTrend Diagnostic Test immunoassay is a biochemical test that measures the presence of these three auto-antibodies.[1]
Notable studies[edit | edit source]
- 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome[2] (Full Text)
Learn more[edit | edit source]
References[edit | edit source]
- ↑ http://www.celltrend.de/cfs-diagnostics.html
- ↑ Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016), "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome", Brain, behavior, and immunity, 52: 32-39, doi:10.1016/j.bbi.2015.09.013
